PRECIGEN Investors


Precigen R&D Update Virtual Event

Dec 15, 2020 at 11:00 AM EST

Precigen hosted a virtual event to provide an update on the latest progress for its clinical pipeline. The event showcased data from several of the Company’s most advanced clinical programs, such as PRGN-3005 UltraCAR-T®, PRGN-3006 UltraCAR-T® and AG019 ActoBioticsTM.

Supporting Materials